AJP - Cell Physiology, Vol 261, Issue 2 C237-C245, Copyright © 1991 by American Physiological Society

ARTICLES

Altered binding site for Ca2+ in the ryanodine receptor of human malignant hyperthermia

H. H. Valdivia, K. Hogan and R. Coronado
Department of Physiology, University of Wisconsin Medical School, Madison 53706.

The binding properties of [3H]ryanodine, a specific ligand of the receptor complex that forms the Ca2+ release channel of sarcoplasmic reticulum, were studied in normal (N) and malignant hyperthermia-susceptible (MH) human skeletal muscle. Integrity of the solubilized ryanodine receptor was demonstrated by single-channel recordings in planar bilayers and by the changes produced by activators and inhibitors of the Ca2+ release channel on the binding properties of [3H]ryanodine. N and MH receptors were capable of binding [3H]ryanodine in a Ca(2+)-dependent manner. Scatchard analysis showed that a single binding site for [3H]ryanodine was present in either N or MH muscle. Binding affinity was approximately the same in N and MH (Kd approximately 7 nM), when the Ca2+ concentration was greater than 30 microM. At 0.3 microM Ca2+, MH receptors displayed a higher affinity for [3H]ryanodine (Kd = 4.1 +/- 1.0 nM) than N receptors (Kd = 7.1 +/- 0.8 nM). The presence of a single Kd for [3H]ryanodine in MH muscle, distinct from that of N muscle, indicated that MH muscle does not have detectable levels of N receptors. Ca2+ dependence of [3H]ryanodine binding further suggested that MH receptors had a higher affinity for Ca2+ (Kd[Ca2+] = 120 +/- 50 nM) than N receptors (Kd[Ca2+] = 250 +/- 80 nM). Caffeine increased [3H]ryanodine binding at submicromolar [Ca2+], and the effect was larger in MH. Apparent affinity constants for caffeine were 13 +/- 1.8 mM in N and 6 +/- 0.8 mM in MH receptors. Evidently, the ryanodine receptor of MH-susceptible human skeletal muscle has an unusually high sensitivity to Ca2+ which is augmented by caffeine.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. Glover, J. J. A. Heffron, and K. Ohlendieck Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle J Appl Physiol, January 1, 2004; 96(1): 11 - 18. [Abstract] [Full Text] [PDF]

				M. Fill and J. A. Copello Ryanodine Receptor Calcium Release Channels Physiol Rev, October 1, 2002; 82(4): 893 - 922. [Abstract] [Full Text] [PDF]

				G. D. Lamb, G. S. Posterino, T. Yamamoto, and N. Ikemoto Effects of a domain peptide of the ryanodine receptor on Ca2+ release in skinned skeletal muscle fibers Am J Physiol Cell Physiol, July 1, 2001; 281(1): C207 - C214. [Abstract] [Full Text] [PDF]

				P. J. Lynch, J. Tong, M. Lehane, A. Mallet, L. Giblin, J. J. A. Heffron, P. Vaughan, G. Zafra, D. H. MacLennan, and T. V. McCarthy A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease PNAS, March 30, 1999; 96(7): 4164 - 4169. [Abstract] [Full Text] [PDF]

				R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF]